Shira Habermehl, in Richmond, VT - Speech-Language Pathologist

Shira Habermehl, is a Speech-language Pathologist based in Richmond, Vermont. Shira Habermehl is licensed to practice in Vermont (license number 8064993) and her current practice location is 343 Jericho Rd Apt A, Richmond, Vermont. She can be reached at her office (for appointments etc.) via phone at (631) 912-5977.

NPI number for Shira Habermehl is 1942915152 and her current mailing address is 343 Jericho Rd Apt A, Richmond, Vermont. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1942915152.

Contact Information

	Shira Habermehl,
	343 Jericho Rd Apt A, Richmond, VT 05477-9173
	(631) 912-5977
	Not Available

Healthcare Provider's Profile

Full Name	Shira Habermehl
Gender	Female
Speciality	Speech-language Pathologist
Location	343 Jericho Rd Apt A, Richmond, Vermont
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1942915152
Provider Enumeration Date: 01/23/2023
Last Update Date: 01/23/2023

Medical Identifiers

Medical identifiers for Shira Habermehl such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1942915152	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	8064993 (Vermont)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shira Habermehl is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shira Habermehl, 343 Jericho Rd Apt A, Richmond, VT 05477-9173 Ph: (631) 912-5977	Shira Habermehl, 343 Jericho Rd Apt A, Richmond, VT 05477-9173 Ph: (631) 912-5977

News Archive

Scientists discover a new method to produce gold nanoparticles

Gold nanoparticles, tiny pieces of gold so small that they can't be seen by the naked eye, are used in electronics, healthcare products and as pharmaceuticals to fight cancer. Despite their positive uses, the process to make the nanoparticles requires dangerous and extremely toxic chemicals. While the nanotechnology industry is expected to produce large quantities of nanoparticles in the near future, researchers have been worried about the environmental impact of the global nanotechnological revolution.

Pepscan reaches partnering agreement for therapeutic vaccine portfolio with Immunovo

Pepscan, the Netherlands based biotechnology firm focusing on protein mimicking technology for the generation of immune therapeutics, today announced that it reached a partnering agreement for its therapeutic vaccine portfolio with Immunovo BV of 's-Hertogenbosch. Under the terms of the agreement Pepscan will receive an undisclosed cash payment as well as a minority interest in Immunovo.

Study finds abnormal fetal circulation as a risk factor for fetal thrombotic vasculopathy

Examination of the placenta can offer answers to the questions that arise following an adverse perinatal outcome, such as stillbirth or intrauterine growth restriction. A placental lesion known as fetal thrombotic vasculopathy (FTV) has been associated with a number of adverse outcomes. By studying placentas with this lesion, researchers hope to determine the risks of such serious complications that affect fetuses and newborns.

Scientists create new way to detect COVID-19 proteins and antibodies

Scientists have created a new way to detect the proteins that make up the pandemic coronavirus, as well as antibodies against it. They designed protein-based biosensors that glow when mixed with components of the virus or specific COVID-19 antibodies.

Use of the drug etodolac instead of drugs like Celebrex or Bextra could save $40 million annually

People in search of pain relief who take the generic anti-inflammatory etodolac suffer 60 percent fewer gastrointestinal complications than those who take similar drugs, according to researchers at UT Southwestern Medical Center at Dallas and the Dallas Veterans Affairs Medical Center.

Speech-Language Pathologist in Richmond, VT

Julia Violet Vitale, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 343 Jericho Rd Unit A, Richmond, VT 05477 Phone: 908-246-5110
Flowstate Speech And Language Therapy Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 343 Jericho Rd Apt A, Richmond, VT 05477 Phone: 631-912-5977
Jodi Russell, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 386 Collins Mountain Rd, Richmond, VT 05477 Phone: 802-434-7633
Susan Empie, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 225 Daniel Ln, Richmond, VT 05477 Phone: 802-434-5214
Stephanie Spencer O'leary, M.S. C.C.C.-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1198 Hinesburg Rd, Richmond, VT 05477 Phone: 802-434-4493

Shira Habermehl, - Speech-Language Pathologist in Richmond, VT